SMPD1 Gene Niemann-Pick Disease Type A/B Genetic Test in UAE | 2,800 AED

Executive Summary & Core Metrics

✓ 99.9% Diagnostic Sensitivity — ISO-accredited NGS laboratory process.
✓ Premium Home Collection — Hospital-grade cold-chain logistics via certified mobile phlebotomists (8 AM–11 PM).
✓ Clinical Guidance — Post-test telephonic interpretation with a genetic counselor.
✓ Insurance Support — Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The SMPD1 Genetic Test is a next-generation sequencing assay that identifies pathogenic variants in the SMPD1 gene responsible for Niemann-Pick disease types A and B, enabling precise diagnosis and family risk assessment. This test is processed in our ISO 9001:2015-certified laboratory with pre- and post-test genetic counseling to support clinical decisions. The NGS methodology covers all point mutations, insertions, deletions, and copy-number changes in the SMPD1 gene, providing a molecular confirmation that traditional enzyme assays cannot achieve.

Feature	Our SMPD1 NGS Test	Alternative Enzyme Assay
Methodology	Next-Generation Sequencing (full gene)	Fluorometric sphingomyelinase activity
Diagnostic Sensitivity	99.9%	85–90% (may miss rare variants)
Scope	All point mutations, indels, and copy-number changes	Enzyme activity only; no genetic detail
Turnaround Time	3–4 weeks	2–3 weeks
Price	2,800 AED	~1,500 AED

Physician Insight & Safety Protocols

“Every genetic result affects not just the patient but the whole family. The SMPD1 analysis can clarify a long-standing diagnostic question, but it must be correlated with clinical findings and family history. I encourage you to discuss implications with a certified genetic counselor or metabolic specialist to ensure holistic care.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory: Medication and Clinical Management

⚠️ Medication Precautions

Do not discontinue prescribed medication without consulting your doctor. Genetic results do not replace current therapeutic regimens or clinical management prescribed by your healthcare provider.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Severe hemophilia, active systemic infection, or inability to provide a blood/DNA sample of adequate quality. Minors must have a legal guardian’s informed consent under Federal Law No. 3 of 2016 (Child Rights Law).
Red Flags (Seek Emergency Care): Sudden severe abdominal pain, intractable vomiting, new-onset seizures, acute respiratory distress, or rapid neurological deterioration after the test. These may indicate disease progression, not a test complication.
Service adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability, Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).

Patient FAQ & Clinical Guidance

1. What is the SMPD1 NGS test and why is it needed?

The SMPD1 gene NGS test detects mutations causing Niemann-Pick disease types A and B for definitive diagnosis. It is recommended when clinical signs such as hepatosplenomegaly, neurological regression, or family history suggest a lysosomal storage disorder. The test provides molecular confirmation that traditional enzyme assays cannot offer, enabling accurate prognosis and family planning.

2. How is the sample collected and what is the turnaround time?

We offer home blood, DNA, or FTA card collection by certified phlebotomists; results within 3–4 weeks. A licensed nurse visits your location (8 AM–11 PM) to draw a small blood sample or collect a dried blood spot on an FTA card. Alternatively, previously extracted DNA can be used. Samples are transported in temperature-controlled kits to our ISO-certified lab, and the comprehensive NGS analysis is completed in 3–4 weeks.

3. What do positive or negative results mean?

Positive SMPD1 result confirms Niemann-Pick A/B, guides symptom care; negative significantly lowers Niemann-Pick A/B suspicion. A positive report identifies one or two pathogenic SMPD1 variants, confirming diagnosis and carrier status, which directs clinical management and genetic counseling. A negative result makes Niemann-Pick type A/B unlikely, but other genetic or metabolic causes may still exist—further evaluation by a specialist is advised.

UAE Regulatory & Data Privacy Adherence

This service is fully compliant with UAE federal data protection standards. All patient data is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory maintains ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under the regulatory oversight of the Dubai Health Authority.

Clinical & Logistical Metadata

Test Name	SMPD1 Gene Niemann-Pick Disease Type A/B Sequencing (NGS)
Price (AED)	2,800 AED
Turnaround Time	3–4 weeks
Sample Type / Matrix	Whole Blood (EDTA), Dried Blood Spot (FTA card), or Extracted DNA; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Methodology Used	Next-Generation Sequencing (full gene, including intronic regions)
ICD-10-CM Code	E75.24 (Niemann-Pick disease)
LOINC Code	81418-7 (SMPD1 gene full sequencing)
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab Branding: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians